Alphalyse

Executive Summary

Alphalyse is a Denmark-based contract protein analysis service laboratory established in 2000, specializing in mass spectrometry-based characterization of biologics. The company delivers critical analytical services, particularly host cell protein (HCP) analysis and product characterization, to support the development and manufacturing of biologic drugs, vaccines, and advanced therapies. By helping clients optimize their CMC processes and meet regulatory requirements, Alphalyse plays an essential role in the biopharmaceutical value chain. The company's long-standing presence and niche expertise position it as a reliable partner for both established pharma and emerging biotech firms.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Service Portfolio into Novel Modalities60% success
• TBDStrategic Partnership with a Major Biopharma Company40% success
• Q4 2026Adoption of Next-Generation Mass Spectrometry Platforms70% success